Intravitreal interferon alpha-2b for the treatment of neovascular age-related macular degeneration: a pilot study

Can J Ophthalmol. 1997 Apr;32(3):185-8.

Authors

P J Kertes¹, W A Britton Jr, B C Leonard

Affiliation

¹ University of Ottawa Eye Institute, Ont.

PMID: 9131284

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Agents / administration & dosage
Antineoplastic Agents / therapeutic use*
Choroid / blood supply*
Electroretinography
Fluorescein Angiography
Follow-Up Studies
Fovea Centralis
Fundus Oculi
Humans
Injections
Interferon alpha-2
Interferon-alpha / administration & dosage
Interferon-alpha / therapeutic use*
Macular Degeneration / complications*
Macular Degeneration / physiopathology
Middle Aged
Neovascularization, Pathologic / etiology
Neovascularization, Pathologic / physiopathology
Neovascularization, Pathologic / therapy*
Pilot Projects
Recombinant Proteins
Safety
Visual Acuity
Vitreous Body

Substances

Antineoplastic Agents
Interferon alpha-2
Interferon-alpha
Recombinant Proteins